SEQSTER Launches 1-Click DataLake Platform to Transform Clinical Trial Design and Recruitment
核心洞察
SEQSTER (搜索) has launched 1-Click DataLake (搜索), a real-world data platform providing access to longitudinal data from over 150 million de-identified patients and 200,000 clinicians across the United States.
The platform leverages more than a decade of aggregated electronic health record data to accelerate clinical trial design, patient recruitment, and real-world evidence generation.
The system features deep integration with diverse and historically underserved populations, supporting FDA mandates for increased diversity in clinical trials.
SEQSTER (搜索) PDM, Inc., a leading healthcare technology company specializing in patient health data orchestration, has announced the launch of its 1-Click DataLake (搜索) platform, designed to accelerate clinical trial design, recruitment, and evidence generation for life sciences and healthcare organizations. The platform provides access to real-world data from more than 150 million de-identified patients and 200,000 clinicians nationwide.
Platform Capabilities and Data Infrastructure
Built on over a decade of aggregated electronic health record (EHR) data, the 1-Click DataLake (搜索) platform securely queries patient-consented records to deliver real-time, longitudinal visibility into patient journeys. These insights support advanced analytics and real-world evidence (RWE) generation to inform trial design, feasibility assessments, and execution.
"We are turning health data into medicine for our clients," said Ardy Arianpour, CEO and Co-Founder of SEQSTER (搜索). "With longitudinal, research-ready data from 150M+ patients, we're now providing a turnkey real world data infrastructure that accelerates study design, optimizes patient recruitment, and enables evidence generation. By rapidly unlocking insights directly from real clinical encounters, our platform delivers a step-change in speed, scale, and intelligence across the clinical research lifecycle."
Addressing Diversity in Clinical Trials
SEQSTER (搜索)'s queryable platform spans a broad range of practices and specialties and includes deep integration with diverse and historically underserved populations. This capability directly supports recent FDA mandates promoting diversity in clinical trials, helping sponsors ensure that studies better reflect the populations they intend to serve.
The platform includes robust patient populations across a wide range of therapeutic areas, enabling precise cohort identification and more effective recruitment strategies. This comprehensive approach addresses longstanding challenges in clinical research related to patient diversity and representation.
Industry Showcase and Future Applications
SEQSTER (搜索) is showcasing its 1-Click DataLake (搜索) platform at the Precision Medicine World Conference 2026 as part of the event's AI and Data Sciences Showcase, where leading AI companies present the newest technologies transforming drug development, clinical research, and patient care.
The platform represents SEQSTER (搜索)'s broader mission of connecting, collecting, and refining patient-consented health data across care settings into a unified, longitudinal patient view. Founded in 2016, the company aims to shape a new era in healthcare by connecting patients, data, and AI to enable faster, smarter, and more trustworthy clinical and research decisions.